Assessing the post marketing experience of Clopidogrel and major cardiovascular events after PCI in Saudi Arabia using the Saudi Food and Drug Authority (SFDA) spontaneous reporting system-MedSci.cn

Assessing the post marketing experience of Clopidogrel and major cardiovascular events after PCI in Saudi Arabia using the Saudi Food and Drug Authority (SFDA) spontaneous reporting system

Alolayet, R; Alnuaim, A; AlHarbi, M; Al-Shahrani, MS

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021; 30 (): 144

科室
- - 订阅+
  - 更多科室
工具
服务